» Articles » PMID: 17451628

Mild Cognitive Impairment As Predictor for Alzheimer's Disease in Clinical Practice: Effect of Age and Diagnostic Criteria

Overview
Journal Psychol Med
Specialty Psychology
Date 2007 Apr 25
PMID 17451628
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We investigated whether the predictive accuracy of mild cognitive impairment (MCI) for Alzheimer-type dementia (AD) in a clinical setting is dependent on age and the definition of MCI used.

Method: Non-demented subjects older than 40 (n=320) who attended a memory clinic of a university hospital were reassessed 5 years later for the presence of AD. MCI was diagnosed according to the criteria of amnestic MCI, mild functional impairment (MFI), ageing-associated cognitive decline (AACD), and age-associated memory impairment (AAMI). The main outcome measure was the area under the curve (AUC) of a receiver operating characteristic (ROC) curve. Analyses were conducted on the entire sample and on subgroups of subjects aged 40-54, 55-69 and 70-85 years.

Results: A diagnosis of AD at follow-up was made in 58 subjects. Four of them were in the 40-54 age group, 29 in the 55-69 age group and 25 in the 70-85 age group. The diagnostic accuracy in the entire sample was low to moderately high with AUCs ranging from 0.56 (AACD) to 0.75 (amnestic MCI). A good predictive accuracy with an AUC >0.80 was only observed in subjects aged 70-85 using the criteria of amnestic MCI (AUC=0.84).

Conclusions: The predictive accuracy of MCI for AD is dependent on age and the definition of MCI used. The predictive accuracy is good only for amnestic MCI in subjects 70-85 years. As subjects with prodromal AD are often younger than 70, the usefulness of MCI as predictor of AD in clinical practice is limited.

Citing Articles

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease.

Pearson M, Wagstaff R, Williams R Brain Behav. 2024; 14(7):e3611.

PMID: 38956818 PMC: 11219301. DOI: 10.1002/brb3.3611.


Development and Effectiveness Verification of Metaverse Cognitive Therapy Contents for MCI Patients.

Oh G, Kim J, Jeong W, Oh S, Whangbo T Sensors (Basel). 2023; 23(13).

PMID: 37447859 PMC: 10346483. DOI: 10.3390/s23136010.


Better prognostic accuracy in younger mild cognitive impairment patients with more years of education.

Gothlin M, Eckerstrom M, Rolstad S, Kettunen P, Wallin A Alzheimers Dement (Amst). 2018; 10:402-412.

PMID: 30094327 PMC: 6072671. DOI: 10.1016/j.dadm.2018.05.001.


Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.

Devlin K, Giovannetti T Neuropsychol Rev. 2017; 27(2):101-123.

PMID: 28536861 DOI: 10.1007/s11065-017-9348-2.


Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.

Fujishima M, Kawaguchi A, Maikusa N, Kuwano R, Iwatsubo T, Matsuda H J Alzheimers Dis. 2016; 56(1):75-88.

PMID: 27911297 PMC: 5240548. DOI: 10.3233/JAD-160621.